Clinical trial · Interventional
SELF-BREATHE RCT for Chronic Breathlessness
A Self - Guided, Internet - Based Intervention for Patients With Chronic Breathlessness (SELF-BREATHE): Feasibility Randomised Controlled Trial
NCT04574050CI-TRIAL-00075165completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A feasibility RCT comprising two groups: 1. Intervention (SELF-BREATHE in addition to standard NHS care) 2. Control group (standard / currently available NHS care)
Conditions
Conditions (12)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Asthma | — | UNRESOLVED | — |
| Bronchiectasis Adult | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Chronic Heart Failure | — | UNRESOLVED | — |
| COPD | — | UNRESOLVED | — |
| Cystic Fibrosis | — | UNRESOLVED | — |
| Dyspnea | — | UNRESOLVED | — |
| Interstitial Lung Disease | — | UNRESOLVED | — |
| Liver Failure | — | UNRESOLVED | — |
| Post COVID-19 | — | UNRESOLVED | — |
| Renal Failure | — | UNRESOLVED | — |
| Sickle Cell Disease |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SELF-BREATHE | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- SELF-BREATHE
- description
- Access to a self -guided, internet -based intervention for patients with chronic breathlessness known as SELF-BREATHE
- interventionNames
- Other: SELF-BREATHE
- type
- NO_INTERVENTION
- label
- Control
- description
- standard / currently available NHS care
Primary outcomes (1)
- measure
- Feasibility: the number of patients recruited into this study over a 12-month period
- timeFrame
- 12 months
- description
- The number of patients recruited into this study over a 12-month period
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults ≥ 18 years of age, with the ability to read and type in English * Access to a computer, or tablet or smart phone, with internet access and the ability to email * Chronic breathlessness (CB) defined as; breathlessness that persists (\>3months) despite optimal pharmacological treatment of the underlying disease including cancer, chronic obstructive pulmonary disease (COPD),asthma, interstitial lung disease (ILD), bronchiectasis, cystic fibrosis (CF) chronic heart failure (CHF), sickle cell disease, chronic renal/ liver failure or post COVID-19 * Chronic breathlessness at rest or on exertion; MRC dysponea score \>2 * Willing to engage with short-term self-guided internet-based breathlessness intervention (SELF-BREATHE) * Able to provide informed consent Exclusion Criteria: * Breathlessness of unknown cause * A primary diagnosis of chronic hyperventilation syndrome * Currently participating in a rehabilitation programme, e.g. pulmonary/cardiac rehabilitation
References
Publications (0)
Data not yet available
No reference posted for this study.